| Cat. No. |
Product Name |
Information |
| PC-35507 |
MSX-3 hydrate
A2AR antagonist
|
MSX-3 hydrate is a potent, specific adenosine A2A receptor (A2AR) antagonist. |
| PC-35297 |
TP455
A2AR antagonist
|
TP455 (TP-455) is a highly potent, selective A2A adenosine receptor inverse agonist with IC50 of 1.9 nM in cyclic AMP assays in hA2A CHO cells. |
| PC-35002 |
BAY 60-6583
A2BR agonist
|
BAY 60-6583 (BAY606583) is a potent, selective adenosine A2B receptor agonist with EC50 of 2.83 nM (murine A2BR). |
| PC-63435 |
Neladenoson dalanate hydrochloride
A1AR agonist
|
Neladenoson dalanate (BAY 10-67197) is a potent, selective, orally acitve partial adenosine A1 receptor (A1AR) agonist (EC50=0.1 nM) for the treatment of chronic heart failure. |
| PC-63434 |
Neladenoson dalanate
A1AR agonist
|
Neladenoson dalanate (BAY 10-67197) is a potent, selective, orally acitve partial adenosine A1 receptor (A1AR) agonist (EC50=0.1 nM) for the treatment of chronic heart failure. |
| PC-43415 |
LUF6000
A3AR modulator
|
LUF6000 is a potent, selective, positive allosteric modulator (enhancer) of human A3 adenosine receptor, enhance Emax but without affecting agonist potency. |
| PC-43386 |
CGS 21680 hydrochloride
A2AR agonist
|
CGS 21680 hydrochloride is a specific adenosine A2A subtype receptor agonist with Ki of 27 nM. |
| PC-43385 |
CGS 21680
A2AR agonist
|
CGS 21680 is a specific adenosine A2A subtype receptor agonist with Ki of 27 nM. |
| PC-43007 |
2-Cl-IB-MECA
A3AR agonist
|
2-Cl-IB-MECA (Chloro-IB-MECA, CF-102, Namodenoson) is a potent, selective A3 adenosine receptor (A3AR) agonist with Ki of 0.33 nM, 2500- and 1400-fold selectivity over A1 and A2a receptors. |
| PC-63144 |
AZD4635
A2AR inhibitor
|
AZD4635 (Imaradenant, HTL 1071) is a potent, selective and orally available adenosine 2A receptor (A2AR) inhibitor with Ki of 1.7 nM, > 30-fold selectivity over other adenosine receptors. |
| PC-63020 |
SCH 412348
A2AR antagonist
|
SCH 412348 is a potent and highly selective A2A receptor competitive antagonist with Ki of 0.6 nM. |
| PC-61367 |
Ciforadenant
A2AR antagonist
|
Ciforadenant (CPI-444, V 81444) is a potent, orally active, adenosine A2A receptor antagonist that is being investigated in solid tumors as a single agent and in combination with the anti-PD-L1 antibody atezolizumab. |
